Published in Medical Letter on the CDC and FDA, November 12th, 2000
Many drugs still effective against parasitic diseases are either no longer available, no longer manufactured, or in danger of being pulled from the market simply because they are not economically viable, say researchers from the Baylor College of Medicine and the U.S. Centers for Disease Control and Prevention (CDC) at a presentation during the annual meeting of the American Society of Tropical Medicine and Hygiene in October 2000.
"Parasites are a very common causes of disease in the world but because there is no market for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA